Thamsanqa Chiliza
Thamsanqa-Chiliza 

Dr Thami Chiliza joined UKZN in 2012 after 7 years as a Researcher in the Biotechnology R&D Industry. His experienced in molecular biology techniques, recombinant protein production, and the development of monoclonal antibodies using hybridoma and phage display techniques.

His current research focuses on Mycobacterium tuberculosis (Mtb) extracellular proteins (secretome) involved in the host-pathogen interaction. He investigates Mtb derived proteins involve host cell invasion (i.e. adhesins) and recognized by tuberculosis (TB) patients immune responses (B-cell and T-cell immune responses) for identification of novel Mtb biomarkers for use in design of new TB vaccines, diagnostic tools & monitoring of TB treatments.

Dr Thami Chiliza joined UKZN in 2012 after 7 years as a Researcher in the Biotechnology R&D Industry. His experienced in molecular biology techniques, recombinant protein production, and the development of monoclonal antibodies using hybridoma and phage display techniques. 

His current research focuses on Mycobacterium tuberculosis (Mtb) extracellular proteins (secretome) involved in the host-pathogen interaction. He investigates Mtb derived proteins involve host cell invasion (i.e. adhesins) and recognized by tuberculosis (TB) patients immune responses (B-cell and T-cell immune responses) for identification of novel Mtb biomarkers for use in design of new TB vaccines, diagnostic tools & monitoring of TB treatments. 
Dr Thami Chiliza joined UKZN in 2012 after 7 years as a Researcher in the Biotechnology R&D Industry. His experienced in molecular biology techniques, recombinant protein production, and the development of monoclonal antibodies using hybridoma and phage display techniques. 

His current research focuses on Mycobacterium tuberculosis (Mtb) extracellular proteins (secretome) involved in the host-pathogen interaction. He investigates Mtb derived proteins involve host cell invasion (i.e. adhesins) and recognized by tuberculosis (TB) patients immune responses (B-cell and T-cell immune responses) for identification of novel Mtb biomarkers for use in design of new TB vaccines, diagnostic tools & monitoring of TB treatments.
 Quote:   'One answer to initial research question gives rise to many follow-up questions only to be answered through further research. Isn’t that exciting? Just a thought….'
Position:   Developmental Lecturer & Researcher
Qualifications:   PhD - currently studying towards
MSc (University of Pretoria)
BSc Hons (University of KwaZulu-Natal)
     
Discipline:   Microbiology
Campus:   Westville
Telephone:   031 260 8985
 Email:   Chilizat@ukzn.ac.za
     
 Research Areas:  

Mycobacterium tuberculosis

Biomarker discovery

Vaccinomics

Infectious diseases

Host immune responses

     
 Recent Publications:  

Naidoo N, Pillay B, Bubb M, Pym A, Chiliza TE, Naidoo K, Ndung'u T, Kasprowicz VO & M Pillay. 2018. Evaluation of a synthetic peptide for the detection of anti-Mycobacterium tuberculosis curli pili IgG antibodies in patients with pulmonary tuberculosis. Tuberculosis 109: 80-84. https://doi.org/10.1016/j.tube.2018.01.007

Chiliza TE, Pillay M & B Pillay. 2017. Identification of unique essential proteins from a Mycobacterium tuberculosis F15/LAM4/KZN phage secretome library. Pathogens and disease, 75(1):ftx001. https://doi.org/10.1093/femspd/ftx001

     

Contact Webmaster | View the Promotion of Access to Information Act | View our Privacy Policy
© University of KwaZulu-Natal: All Rights Reserved.